The Authority also noted, in its 14 March 2018 opinion, that the administration of green tea extracts under fasting conditions, and as a bolus, leads to a significant increase in the area under the plasma concentration-time curve of (-)- epigallocatechin-3-gallate compared to administration with food and in split doses, and that fasting has been demonstrated to increase the toxicity of green tea catechins in experimental animals. Therefore, it is necessary to warn consumers not to consume green tea extract preparations in foods on an empty stomach.
Recital 15, Regulation (EU) 2022/2340
In force